330 related articles for article (PubMed ID: 25972024)
1. Impact of Sustained Eradication of New Pseudomonas aeruginosa Infection on Long-term Outcomes in Cystic Fibrosis.
Mayer-Hamblett N; Kloster M; Rosenfeld M; Gibson RL; Retsch-Bogart GZ; Emerson J; Thompson V; Ramsey BW
Clin Infect Dis; 2015 Sep; 61(5):707-15. PubMed ID: 25972024
[TBL] [Abstract][Full Text] [Related]
2. The success of the different eradication therapy regimens for Pseudomonas aeruginosa in cystic fibrosis.
Emiralioglu N; Yalcin E; Meral A; Sener B; Dogru D; Ozcelik U; Kiper N
J Clin Pharm Ther; 2016 Aug; 41(4):419-23. PubMed ID: 27311742
[TBL] [Abstract][Full Text] [Related]
3. Open label study of inhaled aztreonam for Pseudomonas eradication in children with cystic fibrosis: The ALPINE study.
Tiddens HA; De Boeck K; Clancy JP; Fayon M; H G M A; Bresnik M; Derchak A; Lewis SA; Oermann CM;
J Cyst Fibros; 2015 Jan; 14(1):111-9. PubMed ID: 25091537
[TBL] [Abstract][Full Text] [Related]
4. Initial Pseudomonas aeruginosa treatment failure is associated with exacerbations in cystic fibrosis.
Mayer-Hamblett N; Kronmal RA; Gibson RL; Rosenfeld M; Retsch-Bogart G; Treggiari MM; Burns JL; Khan U; Ramsey BW;
Pediatr Pulmonol; 2012 Feb; 47(2):125-34. PubMed ID: 21830317
[TBL] [Abstract][Full Text] [Related]
5. Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial.
Mayer-Hamblett N; Retsch-Bogart G; Kloster M; Accurso F; Rosenfeld M; Albers G; Black P; Brown P; Cairns A; Davis SD; Graff GR; Kerby GS; Orenstein D; Buckingham R; Ramsey BW;
Am J Respir Crit Care Med; 2018 Nov; 198(9):1177-1187. PubMed ID: 29890086
[TBL] [Abstract][Full Text] [Related]
6. Eradication failure of newly acquired Pseudomonas aeruginosa isolates in cystic fibrosis.
Cohen-Cymberknoh M; Gilead N; Gartner S; Rovira S; Blau H; Mussaffi H; Rivlin J; Gur M; Shteinberg M; Bentur L; Livnat G; Aviram M; Picard E; Tenenbaum A; Armoni S; Breuer O; Shoseyov D; Kerem E
J Cyst Fibros; 2016 Nov; 15(6):776-782. PubMed ID: 27143583
[TBL] [Abstract][Full Text] [Related]
7. Challenges with current inhaled treatments for chronic Pseudomonas aeruginosa infection in patients with cystic fibrosis.
Greally P; Whitaker P; Peckham D
Curr Med Res Opin; 2012 Jun; 28(6):1059-67. PubMed ID: 22401602
[TBL] [Abstract][Full Text] [Related]
8. Intravenous versus oral antibiotics for eradication of Pseudomonas aeruginosa in cystic fibrosis (TORPEDO-CF): a randomised controlled trial.
Hewer SCL; Smyth AR; Brown M; Jones AP; Hickey H; Kenna D; Ashby D; Thompson A; Williamson PR;
Lancet Respir Med; 2020 Oct; 8(10):975-986. PubMed ID: 33007285
[TBL] [Abstract][Full Text] [Related]
9. Comparison of two treatment regimens for eradication of Pseudomonas aeruginosa infection in children with cystic fibrosis.
Proesmans M; Vermeulen F; Boulanger L; Verhaegen J; De Boeck K
J Cyst Fibros; 2013 Jan; 12(1):29-34. PubMed ID: 22762867
[TBL] [Abstract][Full Text] [Related]
10. Nebulized gentamicin in combination with systemic antibiotics for eradicating early Pseudomonas aeruginosa infection in children with cystic fibrosis.
Van Stormbroek B; Zampoli M; Morrow BM
Pediatr Pulmonol; 2019 Apr; 54(4):393-398. PubMed ID: 30656856
[TBL] [Abstract][Full Text] [Related]
11. Pseudomonas aeruginosa phenotypes associated with eradication failure in children with cystic fibrosis.
Mayer-Hamblett N; Ramsey BW; Kulasekara HD; Wolter DJ; Houston LS; Pope CE; Kulasekara BR; Armbruster CR; Burns JL; Retsch-Bogart G; Rosenfeld M; Gibson RL; Miller SI; Khan U; Hoffman LR
Clin Infect Dis; 2014 Sep; 59(5):624-31. PubMed ID: 24863401
[TBL] [Abstract][Full Text] [Related]
12. A real world evaluation of the long-term efficacy of strategies to prevent chronic Pseudomonas aeruginosa pulmonary infection in children with cystic fibrosis.
Mostofian F; Alkadri J; Tang K; Thampi N; Radhakrishnan D
Int J Infect Dis; 2019 Aug; 85():92-97. PubMed ID: 31132474
[TBL] [Abstract][Full Text] [Related]
13. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
[TBL] [Abstract][Full Text] [Related]
14. Association of Intensity of Antipseudomonal Antibiotic Therapy With Risk of Treatment-Emergent Organisms in Children With Cystic Fibrosis and Newly Acquired Pseudomonas Aeruginosa.
Cogen JD; Onchiri FM; Hamblett NM; Gibson RL; Morgan WJ; Rosenfeld M
Clin Infect Dis; 2021 Sep; 73(6):987-993. PubMed ID: 33693586
[TBL] [Abstract][Full Text] [Related]
15. [Early antibiotic treatment for eradication of initial infection by Pseudomonas aeruginosa in patients with cystic fibrosis].
Giugno H; Castaños C; Lubatti A; Pinheiro JL; Hernández C; González Pena H
Arch Argent Pediatr; 2010 Apr; 108(2):141-7. PubMed ID: 20467710
[TBL] [Abstract][Full Text] [Related]
16. Early eradication therapy against Pseudomonas aeruginosa in cystic fibrosis patients.
Taccetti G; Campana S; Festini F; Mascherini M; Döring G
Eur Respir J; 2005 Sep; 26(3):458-61. PubMed ID: 16135728
[TBL] [Abstract][Full Text] [Related]
17. Standard care versus protocol based therapy for new onset Pseudomonas aeruginosa in cystic fibrosis.
Mayer-Hamblett N; Rosenfeld M; Treggiari MM; Konstan MW; Retsch-Bogart G; Morgan W; Wagener J; Gibson RL; Khan U; Emerson J; Thompson V; Elkin EP; Ramsey BW; ;
Pediatr Pulmonol; 2013 Oct; 48(10):943-53. PubMed ID: 23818295
[TBL] [Abstract][Full Text] [Related]
18. Effectiveness of a stepwise Pseudomonas aeruginosa eradication protocol in children with cystic fibrosis.
Blanchard AC; Horton E; Stanojevic S; Taylor L; Waters V; Ratjen F
J Cyst Fibros; 2017 May; 16(3):395-400. PubMed ID: 28189634
[TBL] [Abstract][Full Text] [Related]
19. Clinical Outcomes of Antipseudomonal versus Other Antibiotics among Children with Cystic Fibrosis without
Cogen JD; Faino AV; Onchiri F; Gibson RL; Hoffman LR; Nichols DP; Rosenfeld M; Kronman MP
Ann Am Thorac Soc; 2022 Aug; 19(8):1320-1327. PubMed ID: 35289740
[No Abstract] [Full Text] [Related]
20. Pseudomonas aeruginosa genotypes acquired by children with cystic fibrosis by age 5-years.
Kidd TJ; Ramsay KA; Vidmar S; Carlin JB; Bell SC; Wainwright CE; Grimwood K;
J Cyst Fibros; 2015 May; 14(3):361-9. PubMed ID: 25563522
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
